Clinical Trial Detail

NCT ID NCT02083250
Title Fludarabine/Clofarabine/Busulfan Combined With SAHA in Acute Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

bone marrow cancer

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

anti-thymocyte globulin

Vorinostat

Busulfan + Clofarabine + Fludarabine

Age Groups: adult child

No variant requirements are available.